Retail sale of other food
MYCOTECH PHARMA AS
Revenue 2024
NOK 3.5m
Operating profit
NOK −29.6m
Equity
NOK 20.2m
Incorporated
2022
Share capital
NOK 11.3m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 3.5m | |
| Total operating costs | 33.1m | |
| Operating profit (EBIT) | −29.6m | |
| Net financial items | −901k | |
| Profit for the year | −24.8m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 55.2m | |
| of which current assets | 32.5m | |
| Equity | 20.2m | |
| Total liabilities | 35.0m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.